The Development, Validation and Supply of Physostigmine Free Base
Ministry of Defence · South West
Key facts
- Closing date
- 28 Apr 2023
- Contract starts
- 30 Oct 2023
- Contract ends
- 29 Oct 2038
- Procedure
- Competitive procedure with negotiation (above threshold)
- Buyer type
- Central government
Description
The Ministry of Defence (MoD) is inviting expressions of interest for a requirement for the provision of Physostigmine Free Base(also known as eserine; chemical name 1,2,3,3aβ,8,8aβ-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). as part of an ongoing product development and anticipated commercialisation.
The initial Physostigmine supplied must be suitable for use in a pivotal Phase I clinical setting and the manufacturing process will produce material which does not add additional non-clinical activities to the overall programme, best endeavours should be taken to remove processing impurities.
The Supplier is to develop, scale-up and validate the manufacturing method for Physostigmine Free Base as an Active Pharmaceutical Ingredient (API) for use in a MoD final medicinal product currently under development. The API must be developed and manufactured according to Good Manufacturing Practice (GMP) and must conform to European Transmissible Spongiform Encephalopathies (TSE) requirements, developed such that Intellectual property (IP) is vested in the Authority.
The Authority intends to seek a Marketing Authorisation for the final medicinal product from the Medicines and Healthcare products Regulatory Agency (MHRA) and Physostigmine will be required as an active ingredient for a future registered medicinal product.
The Supplier is required to provide information necessary for the Authority to complete the Chemistry, Manufacturing and Control (CMC) documentation to support a Clinical Trial Application (CTA) and Marketing Authorisation Application for the final medicinal product and make this documentation available to the MA applicant in an appropriate format for inclusion within CTD Module 3.
The Authority anticipates a Limited Quality by Design (QBD) approach to the manufacturing process as defined by the International Conference on Harmonisation (ICH).
All procurement documents are accessible via www.contracts.mod.uk
Categories (CPV)
- 33661700 Other nervous system medicinal products
Similar open tenders
Global Travel, Accommodation and Venue Management Services
Location: North WestBuyer: Government Commercial Agency
Open tenderCloses 8 Dec, 202633 daysValue £36.25bnSource Find a TenderA framework providing comprehensive booking solutions for all UK Public Sector Travel needs, including air, rail, taxis, coaches, car hire, accommodation and venues for meetings, conferences and events, as well as emergency travel and accommodation solutions, including for civilian cohorts under the care of a UK Public
National Generic Pharmaceuticals – Project Revive
Location: LondonBuyer: NHS England
Open tenderCloses 30 Nov, 202625 daysValue £6.86mSource Find a TenderNational Generic Pharmaceuticals – Project Revive DCE/DSW regions – 01/04/27 to 31/01/29 (22 months) DLS/DNE regions – 01/04/27 to 31/01/29 (22 months) DLN/DNW regions – 01/04/27 to 31/01/29 (22 months)
Orthotic Splints & Braces
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £60.14kSource Find a TenderOrthotic Splints & Braces - RJAH, SATH , SCT
UKRI-6412 MRC Harwell Self-Steam Generating Autoclave
Location: South WestBuyer: UK Research & Innovation (UKRI)
Open tenderCloses 30 Nov, 202625 daysValue £150.00kSource Find a TenderMRC Harwell is seeking to replace the existing autoclave with the supply, installation and acceptance of a self-steaming generating autoclave
Cleanroom Consumables
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 9 Nov, 20264 daysValue £11.91kSource Find a TenderCleanroom Consumables - SATH & SCT
MED0014 - The Supply of Beating Heart Products
Location: United KingdomBuyer: University Hospitals of North Midlands NHS Trust
Open tenderCloses 16 Nov, 202611 daysValue £18.33kSource Find a TenderBeating heart surgery (Off-Pump Coronary Artery Bypass or OPCAB) utilizes specific stabilization equipment rather than a cardiopulmonary bypass machine.